Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2025 Filed Mar 3, 2025 22:57 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionCommon Stock | 20,906 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031090 · ownership.xml · nonDerivative · entry 3 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:57 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionCommon Stock | 9,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031090 · ownership.xml · nonDerivative · entry 2 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:57 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionCommon Stock | 5,894 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031090 · ownership.xml · nonDerivative · entry 1 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:56 UTC |
BURGESS RONALD L JRDirector
|
GrantRestricted Stock Units · Derivative | 59,801 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031089 · ownership.xml · derivative · entry 2 BURGESS RONALD L JR · CIK 0001992493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,519 Underlying: Common Stock · 59,801 shares Expires not disclosed F1 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. F1 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:56 UTC |
Brooks Susan WDirector
|
GrantRestricted Stock Units · Derivative | 59,801 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031088 · ownership.xml · derivative · entry 5 Brooks Susan W · CIK 0001846180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,801 Underlying: Common Stock · 59,801 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:56 UTC |
Brooks Susan WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 20,906 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031088 · ownership.xml · derivative · entry 4 Brooks Susan W · CIK 0001846180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,812 Underlying: Common Stock · 20,906 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:56 UTC |
Brooks Susan WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 9,756 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031088 · ownership.xml · derivative · entry 3 Brooks Susan W · CIK 0001846180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,756 Underlying: Common Stock · 9,756 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:56 UTC |
Brooks Susan WDirector
|
Exercise / conversionCommon Stock | 20,906 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031088 · ownership.xml · nonDerivative · entry 2 Brooks Susan W · CIK 0001846180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 22:56 UTC |
Brooks Susan WDirector
|
Exercise / conversionCommon Stock | 9,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031088 · ownership.xml · nonDerivative · entry 1 Brooks Susan W · CIK 0001846180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| February 21, 2025 Filed Feb 21, 2025 22:59 UTC |
SMITH WAYNE TDirector
|
GiftCommon Stock | 20,336 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-025026 · ownership.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,206,739 F1 · shares: These shares were gifted to individuals who do not share the Reporting Person's household. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:16 UTC |
BENET MIGUEL SPresident and CMO
|
SaleCommon Stock | 23,875 | $3.53 | $84,159.38 |
DisclosureSEC source: 0000950170-25-026691 · ownership.xml · nonDerivative · entry 1 BENET MIGUEL S · CIK 0002044704 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · price: These shares were sold in a series of transactions at a sales price of $3.525 per share. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 20:15 UTC |
Brooks Susan WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 5,894 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-067985 · ownership.xml · derivative · entry 2 Brooks Susan W · CIK 0001846180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,894 Underlying: Common Stock · 5,894 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 20:15 UTC |
Brooks Susan WDirector
|
Exercise / conversionCommon Stock | 5,894 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-067985 · ownership.xml · nonDerivative · entry 1 Brooks Susan W · CIK 0001846180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 20:15 UTC |
LOPEZ FAWN DDirector
|
GrantRestricted Stock Units · Derivative | 62,718 | $3.96 Strike: $0.00 | $248,363.28 |
DisclosureSEC source: 0000950170-24-067986 · ownership.xml · derivative · entry 2 LOPEZ FAWN D · CIK 0002021315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,718 Underlying: Common Stock · 62,718 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. F1 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 20:31 UTC |
Pitt Justin DEVP and General Counsel
|
Disposition to issuerCommon Stock | 5,001 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032237 · ownership.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 12,584 F1 · ownership.nature: The Reporting Person's spouse is no longer employed by an affiliate of the Issuer. The remaining unvested portion of her prior awards of restricted stock was forfeited in conjunction with her ceasing to be employed by an affiate of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:59 UTC |
Hingtgen TimDirector · CEO
|
GrantStock Options (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000950170-24-024240 · ownership.xml · derivative · entry 7 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:59 UTC |
Hingtgen TimDirector · CEO
|
GrantPerformance Based Restricted · Derivative | 400,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024240 · ownership.xml · derivative · entry 6 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:59 UTC |
Hingtgen TimDirector · CEO
|
Disposition to issuerPerformance Based Restricted · Derivative | 40,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024240 · ownership.xml · derivative · entry 5 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires not disclosed F1 · derivative.exercise_date: The vesting of these 200,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (160,000), and the remaining 20% of the target number has been forfeited (40,000). F1 · derivative.expiration_date: The vesting of these 200,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (160,000), and the remaining 20% of the target number has been forfeited (40,000). Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:59 UTC |
Hingtgen TimDirector · CEO
|
Exercise / conversionPerformance Based Restricted · Derivative | 160,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024240 · ownership.xml · derivative · entry 4 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 160,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these 200,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (160,000), and the remaining 20% of the target number has been forfeited (40,000). F1 · derivative.expiration_date: The vesting of these 200,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (160,000), and the remaining 20% of the target number has been forfeited (40,000). Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:59 UTC |
Hingtgen TimDirector · CEO
|
Tax withholdingCommon Stock | 115,428 | $2.87 | $331,278.36 |
DisclosureSEC source: 0000950170-24-024240 · ownership.xml · nonDerivative · entry 3 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,233,988 Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:59 UTC |
Hingtgen TimDirector · CEO
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024240 · ownership.xml · nonDerivative · entry 2 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,349,416 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:59 UTC |
Hingtgen TimDirector · CEO
|
Exercise / conversionCommon Stock | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024240 · ownership.xml · nonDerivative · entry 1 Hingtgen Tim · CIK 0001598637 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,149,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these 200,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (160,000), and the remaining 20% of the target number has been forfeited (40,000). Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:58 UTC |
STOCKTON KEVIN AEVP, Operations & Development
|
GrantStock Options (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000950170-24-024238 · ownership.xml · derivative · entry 6 STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2034-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:58 UTC |
STOCKTON KEVIN AEVP, Operations & Development
|
GrantPerformance Based Restricted · Derivative | 80,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024238 · ownership.xml · derivative · entry 5 STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:58 UTC |
STOCKTON KEVIN AEVP, Operations & Development
|
Exercise / conversionPerformance Based Restricted · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024238 · ownership.xml · derivative · entry 4 STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:58 UTC |
STOCKTON KEVIN AEVP, Operations & Development
|
Tax withholdingCommon Stock | 16,631 | $2.87 | $47,730.97 |
DisclosureSEC source: 0000950170-24-024238 · ownership.xml · nonDerivative · entry 3 STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,732 Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:58 UTC |
STOCKTON KEVIN AEVP, Operations & Development
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024238 · ownership.xml · nonDerivative · entry 2 STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,363 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:58 UTC |
STOCKTON KEVIN AEVP, Operations & Development
|
Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024238 · ownership.xml · nonDerivative · entry 1 STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Simon Lynn TPresident and CMO
|
GrantStock Options (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000950170-24-024237 · ownership.xml · derivative · entry 6 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2034-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Simon Lynn TPresident and CMO
|
GrantPerformance Based Restricted · Derivative | 80,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024237 · ownership.xml · derivative · entry 5 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Simon Lynn TPresident and CMO
|
Exercise / conversionPerformance Based Restricted · Derivative | 80,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024237 · ownership.xml · derivative · entry 4 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Simon Lynn TPresident and CMO
|
Tax withholdingCommon Stock | 47,221 | $2.87 | $135,524.27 |
DisclosureSEC source: 0000950170-24-024237 · ownership.xml · nonDerivative · entry 3 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,657 Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Simon Lynn TPresident and CMO
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024237 · ownership.xml · nonDerivative · entry 2 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529,878 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Simon Lynn TPresident and CMO
|
Exercise / conversionCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024237 · ownership.xml · nonDerivative · entry 1 Simon Lynn T · CIK 0001598823 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 489,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Pitt Justin DEVP and General Counsel
|
GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · derivative · entry 7 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-02-28 F5 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Pitt Justin DEVP and General Counsel
|
GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · derivative · entry 6 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Pitt Justin DEVP and General Counsel
|
Exercise / conversionPerformance Based Restricted · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · derivative · entry 5 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Pitt Justin DEVP and General Counsel
|
Tax withholdingCommon Stock | 1,484 | $2.87 | $4,259.08 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 4 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 17,585 F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Pitt Justin DEVP and General Counsel
|
Tax withholdingCommon Stock | 16,497 | $2.87 | $47,346.39 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 3 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,116 Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Pitt Justin DEVP and General Counsel
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 2 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,613 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC |
Pitt Justin DEVP and General Counsel
|
Exercise / conversionCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
Johnson Jason KSVP & CAO
|
GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000950170-24-024235 · ownership.xml · derivative · entry 6 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
Johnson Jason KSVP & CAO
|
GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024235 · ownership.xml · derivative · entry 5 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
Johnson Jason KSVP & CAO
|
Exercise / conversionPerformance Based Restricted · Derivative | 18,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024235 · ownership.xml · derivative · entry 4 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
Johnson Jason KSVP & CAO
|
Tax withholdingCommon Stock | 15,812 | $2.87 | $45,380.44 |
DisclosureSEC source: 0000950170-24-024235 · ownership.xml · nonDerivative · entry 3 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,343 Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
Johnson Jason KSVP & CAO
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024235 · ownership.xml · nonDerivative · entry 2 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,155 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
Johnson Jason KSVP & CAO
|
Exercise / conversionCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024235 · ownership.xml · nonDerivative · entry 1 Johnson Jason K · CIK 0001798438 · SVP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantStock Options (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000950170-24-024230 · ownership.xml · derivative · entry 7 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2034-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
HAMMONS KEVIN JPresident and CFO
|
GrantPerformance Based Restricted · Derivative | 180,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024230 · ownership.xml · derivative · entry 6 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:56 UTC |
HAMMONS KEVIN JPresident and CFO
|
Disposition to issuerPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024230 · ownership.xml · derivative · entry 5 HAMMONS KEVIN J · CIK 0001542264 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_date: The vesting of these 150,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (120,000), and the remaining 20% of the target number has been forfeited (30,000). F1 · derivative.expiration_date: The vesting of these 150,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (120,000), and the remaining 20% of the target number has been forfeited (30,000). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.